Keith Bossier Joins Ripple Science as Director of Sales
Company’s Growth Leads to Expansion of Ripple Science Team
ANN ARBOR, MICHIGAN – June 3, 2019 – Ripple Science is pleased to announce Keith Bossier has joined the team as the company’s Director of Sales. Keith comes to Ripple Science with over 10 years of sales experience, most recently as a top performer at Salesforce, the leader in customer-relationship management software. While there, he was ranked in the top 2% of Sales Executives in Commercial Sales for North America.
In his new role at Ripple Science, Bossier will report to the CEO with responsibility for building and leading the sales team. In addition, he will be a valuable contributor in the areas of marketing and business strategy. Keith holds a Bachelor of Arts degree from DePaul University and a Master of Business Administration degree from Loyola University Chicago. His background and experience align well with Ripple Science’s mission.
Keith Bossier commented, “As a top performer on a highly competitive B2B sales team at Salesforce, I saw an array of interesting opportunities open up to me. I chose to join Ripple for the opportunity to build my own team around a great product that addresses a real and very costly problem in medical research.”
“Keith brings active knowledge of world-class SaaS sales practices to Ripple,” said Peter Falzon, CEO of Ripple Science. “He’s exactly what we need at this time to plan and execute our B2B growth strategy.”
Ripple Science has recently achieved key milestones securing $1.8 million in new financing and releasing several new product features. These achievements position the company to expand among private clinical trial sites working in partnership with clinical research organizations and biopharma sponsors.
About Ripple Science
Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants, faster and reduces patients lost to follow-up.
Ripple Science’s flagship product, Ripple, is currently being used by research investigators at more than 50 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.